Amnion-Chorion Membrane for Palate Wound Healing
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two treatments to aid wound healing in the mouth after surgery. Researchers aim to determine if a special membrane, amnion-chorion, which contains growth factors that aid healing, is as effective as a common gauze called ActCel. They compare the treatments' effects on healing and the level of pain patients experience afterward. Individuals needing oral surgery between their molars and who have access to a smartphone might be suitable for this trial. As an unphased trial, this study offers a unique opportunity to contribute to medical research and potentially benefit from innovative treatments.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the amnion-chorion membrane (ACM) is generally safe for use in oral surgeries. One study found it effective in repairing cleft palates, as it helped close wounds well after surgery. Another study confirmed its safety when used on mouth wounds.
The amnion-chorion membrane aids in healing wounds, reducing swelling, and supporting tissue growth. These benefits make it a good choice for surgeries in the mouth and jaw area. So far, no major safety issues have been reported with using ACM in these situations.
The current study phase is "Not Applicable," indicating no new data about side effects in this trial yet. However, existing research strongly indicates its safety and effectiveness.12345Why are researchers excited about this trial?
Researchers are excited about the Amnion-Chorion Membrane (ACM) for palate wound healing because it harnesses the power of natural growth factors found in amnion and chorion tissues. Unlike traditional treatments like standard gauze or collagen dressings, ACM offers a biological approach that actively promotes healing by delivering these growth factors directly to the wound site. This innovative method has the potential to speed up recovery and improve overall healing outcomes, making it a promising alternative to existing options.
What evidence suggests that the Amnion-Chorion Membrane is effective for palate wound healing?
This trial will compare the use of the amnion-chorion membrane (ACM) with ActCel Cellulose Gauze for palate wound healing. Studies have shown that ACM aids wound healing by containing substances that promote cell growth and new blood vessel formation. In one study, ACM performed as well as traditional collagen dressings for healing areas after gum surgery. Another study found ACM safe and effective for closing wounds after cleft palate repairs. These findings suggest ACM could be a promising option for improving healing and reducing pain in palate surgeries.26789
Who Is on the Research Team?
Brian L Mealey, DDS, MS
Principal Investigator
University of Texas Health Science Center San Antonio
Are You a Good Fit for This Trial?
This trial is for adults aged 18-89 needing gum surgery in the mouth area from back molar to back molar, whether they have teeth, implants, or none. Participants can be non-smokers or light smokers (less than 10 cigarettes a day), including women who are not pregnant and either post-menopausal, had tubal ligation/hysterectomy, or use contraception. They must also be able to follow up and own a smartphone.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo periodontal plastic surgery with either Amnio-Chorion Membrane or ActCel Cellulose Gauze applied to the palatal donor site
Follow-up
Participants are monitored for wound healing and pain perception post-surgery
What Are the Treatments Tested in This Trial?
Interventions
- ActCel Cellulose Gauze
- Amnion-Chorion Membrane
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center at San Antonio
Lead Sponsor